Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-17-009268
Filing Date
2017-10-27
Accepted
2017-10-26 21:46:26
Documents
13

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1627791
2 GRAPHIC g475892g07q36.jpg GRAPHIC 58587
3 GRAPHIC g475892g14y95.jpg GRAPHIC 68176
4 GRAPHIC g475892g16k55.jpg GRAPHIC 77969
5 GRAPHIC g475892g16r29.jpg GRAPHIC 134269
6 GRAPHIC g475892g16s95.jpg GRAPHIC 115059
7 GRAPHIC g475892g21d19.jpg GRAPHIC 99976
8 GRAPHIC g475892g74c97.jpg GRAPHIC 60787
9 GRAPHIC g475892g77j27.jpg GRAPHIC 63070
10 GRAPHIC g475892g79t13.jpg GRAPHIC 76946
11 GRAPHIC g475892g80i74.jpg GRAPHIC 62158
12 GRAPHIC g475892g80m33.jpg GRAPHIC 43816
13 GRAPHIC g475892g99k81.jpg GRAPHIC 80747
  Complete submission text file 0000950123-17-009268.txt   2926556
Mailing Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET SUITE 6102 BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-01761 | Film No.: 171157758
SIC: 2834 Pharmaceutical Preparations